Autologous hALK.CAR T cells Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Boston, Massachusetts1 trial

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Boston Children's Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.